These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 28165047)
1. Relevance of mortalin to cancer cell stemness and cancer therapy. Yun CO; Bhargava P; Na Y; Lee JS; Ryu J; Kaul SC; Wadhwa R Sci Rep; 2017 Feb; 7():42016. PubMed ID: 28165047 [TBL] [Abstract][Full Text] [Related]
2. Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers. Putri JF; Bhargava P; Dhanjal JK; Yaguchi T; Sundar D; Kaul SC; Wadhwa R J Exp Clin Cancer Res; 2019 Dec; 38(1):499. PubMed ID: 31856867 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Wadhwa R; Takano S; Kaur K; Deocaris CC; Pereira-Smith OM; Reddel RR; Kaul SC Int J Cancer; 2006 Jun; 118(12):2973-80. PubMed ID: 16425258 [TBL] [Abstract][Full Text] [Related]
4. Mortalin sensitizes human cancer cells to MKT-077-induced senescence. Deocaris CC; Widodo N; Shrestha BG; Kaur K; Ohtaka M; Yamasaki K; Kaul SC; Wadhwa R Cancer Lett; 2007 Jul; 252(2):259-69. PubMed ID: 17306926 [TBL] [Abstract][Full Text] [Related]
5. Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity. Pilzer D; Saar M; Koya K; Fishelson Z Int J Cancer; 2010 Mar; 126(6):1428-35. PubMed ID: 19739077 [TBL] [Abstract][Full Text] [Related]
6. Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy. Sane S; Abdullah A; Nelson ME; Wang H; Chauhan SC; Newton SS; Rezvani K Cell Stress Chaperones; 2016 Mar; 21(2):313-26. PubMed ID: 26634371 [TBL] [Abstract][Full Text] [Related]
7. Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus. Yoo JY; Ryu J; Gao R; Yaguchi T; Kaul SC; Wadhwa R; Yun CO J Gene Med; 2010 Jul; 12(7):586-95. PubMed ID: 20603860 [TBL] [Abstract][Full Text] [Related]
8. Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. Lu WJ; Lee NP; Kaul SC; Lan F; Poon RT; Wadhwa R; Luk JM Int J Cancer; 2011 Oct; 129(8):1806-14. PubMed ID: 21165951 [TBL] [Abstract][Full Text] [Related]
9. Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model. Walker C; Böttger S; Low B Am J Pathol; 2006 May; 168(5):1526-30. PubMed ID: 16651619 [TBL] [Abstract][Full Text] [Related]
10. NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness". Bonuccelli G; De Francesco EM; de Boer R; Tanowitz HB; Lisanti MP Oncotarget; 2017 Mar; 8(13):20667-20678. PubMed ID: 28223550 [TBL] [Abstract][Full Text] [Related]
11. Mortalin promotes breast cancer malignancy. Zhang R; Meng Z; Wu X; Zhang M; Zhang S; Jin T Exp Mol Pathol; 2021 Feb; 118():104593. PubMed ID: 33309613 [TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of nuclear mortalin in human carcinogenesis. Ryu J; Kaul Z; Yoon AR; Liu Y; Yaguchi T; Na Y; Ahn HM; Gao R; Choi IK; Yun CO; Kaul SC; Wadhwa R J Biol Chem; 2014 Sep; 289(36):24832-44. PubMed ID: 25012652 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK-ERK pathway. Hu Y; Yang L; Yang Y; Han Y; Wang Y; Liu W; Zuo J J Cell Mol Med; 2016 Nov; 20(11):2111-2121. PubMed ID: 27374312 [TBL] [Abstract][Full Text] [Related]
14. Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo. Wadhwa R; Colgin L; Yaguchi T; Taira K; Reddel RR; Kaul SC Cancer Res; 2002 Aug; 62(15):4434-8. PubMed ID: 12154051 [TBL] [Abstract][Full Text] [Related]
15. Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence. Grover A; Priyandoko D; Gao R; Shandilya A; Widodo N; Bisaria VS; Kaul SC; Wadhwa R; Sundar D Int J Biochem Cell Biol; 2012 Mar; 44(3):496-504. PubMed ID: 22155302 [TBL] [Abstract][Full Text] [Related]
16. Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro. Kang Q; Cai JB; Dong RZ; Liu LX; Zhang C; Zhang PF; Zou H; Xie N; Zhang L; Zhang XY; Song ZJ; Dong ZR; Hu MY; Huang XY; Zhang XW; Ke AW; Shi GM J Clin Pathol; 2017 Aug; 70(8):677-683. PubMed ID: 28096273 [TBL] [Abstract][Full Text] [Related]
17. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Wadhwa R; Sugihara T; Yoshida A; Nomura H; Reddel RR; Simpson R; Maruta H; Kaul SC Cancer Res; 2000 Dec; 60(24):6818-21. PubMed ID: 11156371 [TBL] [Abstract][Full Text] [Related]
18. Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma. Xu M; Jin T; Chen L; Zhang X; Zhu G; Wang Q; Lin Z Gene; 2019 May; 696():63-71. PubMed ID: 30776464 [TBL] [Abstract][Full Text] [Related]
19. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Starenki D; Hong SK; Lloyd RV; Park JI Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367 [TBL] [Abstract][Full Text] [Related]
20. Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in Wu PK; Hong SK; Park JI Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]